Doris M. Benbrook

8.7k citations

144 papers · 5.2k indexed · 1 hit paper · h-index 38

Impact in

Molecular Biology top 2%
- Retinoids in leukemia and cellular processes
- Glycosylation and Glycoproteins Research
Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment

Papers in

Reproductive Medicine 27
- Ovarian cancer diagnosis and treatment 22
- Endometriosis Research and Treatment 7
Biochemistry 17
- Antioxidant Activity and Oxidative Stress 17

Co-authors: Magnus Pfahl Nicholas C. Jones Chioniso Patience Masamha K. Darrell Berlin Aideen Long María A. Ortiz Gilles Salbert Rainer Apfel
Journals: Gynecologic Oncology (22 papers)Journal of Medicinal Chemistry (7 papers)Cancers (6 papers)Molecular Cancer Therapeutics (5 papers)Cancer Research (4 papers)
Partner nations: United States China France

In The Last Decade

Doris M. Benbrook

133 papers receiving 5.1k citations

Hit Papers

align trajectories log scale

A new retinoic acid receptor identified from a hepatocellular carcinoma 1988 · 546 citations

Peers

Countries citing papers authored by Doris M. Benbrook

Since Specialization

Citations

This map shows the geographic impact of Doris M. Benbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris M. Benbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris M. Benbrook more than expected).

Fields of papers citing papers by Doris M. Benbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris M. Benbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris M. Benbrook. The network helps show where Doris M. Benbrook may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Doris M. Benbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Doris M. Benbrook Line = papers co-authored together Doris M. Benbrook links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Implication of fibroblast growth factor 7 in ovarian cancer metastases and patient survival Frontiers in Oncology ·Т Н Полубелова, Jos Tarcísio Lima, 一善宮崎, 厚木勝基, Yusuf Antoni, Doris M. Benbrook	2025	0
2	Mortalin and PINK1/Parkin‐Mediated Mitophagy Represent Ovarian Cancer‐Selective Targets for Drug Development Advanced Science ·Vishal Chandra, 一善宮崎, Rajani Rai, Donghua H. Zhou, Charuksha Walgama, Sadagopan Krishnan, Nayara Natacha de Jesus Pereira, Tongzu Liu, M Tettersell, Doris M. Benbrook	2025	1
3	Cognitive Performance in Relation to Systemic and Brain Iron at Perimenopause Nutrients ·Xiang Kai-xiang, Michael J. Wenger, Zhixiong Yang, Dee Wu, Yusuf Antoni, Doris M. Benbrook, Han Yuan	2025	0
4	Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors. Biomedicine & Pharmacotherapy ·Rajani Rai, Debasish Kumar Dey, Doris M. Benbrook, Vishal Chandra	2023	10
5	Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities International Journal of Molecular Sciences ·Pouya Javadian, Chao Xu, Maria Cоmpean, Qingyan Wu, 一善宮崎, Doris M. Benbrook	2022	6
6	Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity Cancers ·Pouya Javadian, N G Phillips, U Ujiburrohman, Doris M. Benbrook	2021	15
7	Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets Cells ·Rajani Rai, Amy L. Kennedy, Yusuf Antoni, Pouya Javadian, Doris M. Benbrook	2021	41
8	Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer Cancers ·Rajani Rai, C. Lucchinetti, Doris M. Benbrook, 一善宮崎, Yan D. Zhao, Vishal Chandra	2020	25
9	Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer Cancer Letters ·Ana Laís dos Santos Silva, Elangovan Thavathiru, Habeebiah Olalekan OMOTOSO, Kathleen N. Moore, Doris M. Benbrook, Roger G. Harrison	2018	23
10	The pro-inflammatory effect of obesity on high grade serous ovarian cancer Gynecologic Oncology ·Camille C. Gunderson, Kai Ding, Justin Dvorak, Kathleen N. Moore, D. Scott McMeekin, Doris M. Benbrook	2016	6
11	Insulin Exerts Direct Effects on Carcinogenic Transformation of Human Endometrial Organotypic Cultures Cancer Investigation ·Erin Bishop, Stan Lightfoot, Elangovan Thavathiru, Doris M. Benbrook	2014	12
12	Integration of autography, proteasomal degradation, unfolded protein responce and apoptosis The scientific electronic library of periodicals of the National Academy of Sciences of Ukraine (National Academy of Sciences of Ukraine) ·Doris M. Benbrook, Apple Long	2012	3
13	Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study Gynecologic Oncology ·Jean Hurteau, Mark F. Brady, Kathleen M. Darcy, William P. McGuire, Pamela Edmonds, Michael L. Pearl, Ref. Neuendorff, Krishnansu S. Tewari, Robert S. Mannel, Kristine Zanotti, Doris M. Benbrook	2010	56
14	Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells Cancer Research ·Chioniso Patience Masamha, Doris M. Benbrook	2009	174
15	CAAT/Enhancer Binding Protein Homologous Protein–Dependent Death Receptor 5 Induction Is a Major Component of SHetA2-Induced Apoptosis in Lung Cancer Cells Cancer Research ·María Auxiliadora Javaloyes Sanchís, Shuzhen Chen, Ping Yue, Wei Zou, Doris M. Benbrook, Shengquan Liu, Thanh C. Le, K. Darrell Berlin, Fadlo R. Khuri, Shi-Yong Sun	2008	44
16	Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc Cancer Research ·Tongzhong Ju, Grainger S. Lanneau, Tripti Gautam, Yingchun Wang, Baoyun Xia, Sean R. Stowell, Margaret Willard, Wenyi Wang, Jonathan Y. Xia, Rosemary E. Zuna, Zoltán Lászik, Doris M. Benbrook, Marie H. Hanigan, Richard D. Cummings	2008	232
17	SHetA2 targets cyclin D1 for proteasomal degradation through a GSK3β-independent mechanism leading to G1 cell cycle arrest. Molecular Cancer Therapeutics ·Chioniso Patience Masamha, Tongzu Liu, Doris M. Benbrook	2007	2
18	Regulation of apoptosis, cell cycle progression and differentiation by SHetA2 in renal cancer cells is associated with alterations in Bcl-2, cyclin D1 and E-cadherin proteins Molecular Cancer Therapeutics ·Terrence L Howard, Chioniso Patience Masamha, 庸平久世, Doris M. Benbrook, Stan Lightfoot	2007	1
19	High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2 Cancer Chemotherapy and Pharmacology ·Yilong Zhang, Yousheng Hua, Doris M. Benbrook, Joseph M. Covey, Guowei Dai, Zhongfa Liu, Kenneth K. Chan	2006	22
20	Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells Molecular and Cellular Endocrinology ·Przemysław Waliszewski, Jean M. Goutoule, E. N. Jacobsen, Robert E. Hurst, Doris M. Benbrook, H Kuyama, George P. Hemstreet	1999	9

About Doris M. Benbrook

Doris M. Benbrook is a scholar working on Reproductive Medicine, Biochemistry, Obstetrics and Gynecology, Molecular Biology and Genetics, having authored 144 papers that have together received 5.2k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (47 papers), Estrogen and related hormone effects (34 papers), Ovarian cancer diagnosis and treatment (22 papers), Antioxidant Activity and Oxidative Stress (17 papers), Endometrial and Cervical Cancer Treatments (14 papers), Cancer-related Molecular Pathways (12 papers), Reproductive System and Pregnancy (9 papers) and Endometriosis Research and Treatment (7 papers). The work is most often cited by research in Molecular Biology (3.4k citations), Reproductive Medicine (357 citations), Biochemistry (251 citations), Immunology (794 citations) and Genetics (1.0k citations). Doris M. Benbrook has collaborated with scholars based in United States, China and France. Frequent co-authors include Magnus Pfahl, Nicholas C. Jones, Chioniso Patience Masamha, K. Darrell Berlin, Aideen Long, María A. Ortiz, Gilles Salbert, Rainer Apfel, Rajani Rai and Stan Lightfoot. Their work appears in journals such as Gynecologic Oncology, Journal of Medicinal Chemistry, Cancers, Molecular Cancer Therapeutics and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact